Praram 9 Hospital Valuation
Is PR9-R undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of PR9-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: PR9-R (THB26.25) is trading below our estimate of fair value (THB30.07)
Significantly Below Fair Value: PR9-R is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for PR9-R?
Key metric: As PR9-R is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is PR9-R's PE Ratio? | |
|---|---|
| PE Ratio | 29.7x |
| Earnings | ฿694.15m |
| Market Cap | ฿20.64b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 4x |
| Enterprise Value/EBITDA | 16.8x |
| PEG Ratio | 2.6x |
Price to Earnings Ratio vs Peers
How does PR9-R's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 24.4x | ||
SKR Sikarin | 22.4x | n/a | ฿18.9b |
VIBHA Vibhavadi Medical Center | 26.9x | 11.8% | ฿27.5b |
RAM Ramkhamhaeng Hospital | 21.3x | 16.2% | ฿27.5b |
MASTER Master Style | 27.2x | 17.9% | ฿12.7b |
PR9-R Praram 9 Hospital | 29.7x | 11.4% | ฿20.6b |
Price-To-Earnings vs Peers: PR9-R is expensive based on its Price-To-Earnings Ratio (29.7x) compared to the peer average (24.4x).
Price to Earnings Ratio vs Industry
How does PR9-R's PE Ratio compare vs other companies in the TH Healthcare Industry?
| 0 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|
| 0 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Earnings vs Industry: PR9-R is expensive based on its Price-To-Earnings Ratio (29.7x) compared to the TH Healthcare industry average (22x).
Price to Earnings Ratio vs Fair Ratio
What is PR9-R's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 29.7x |
| Fair PE Ratio | 23.3x |
Price-To-Earnings vs Fair Ratio: PR9-R is expensive based on its Price-To-Earnings Ratio (29.7x) compared to the estimated Fair Price-To-Earnings Ratio (23.3x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.